CT-996

Carmot Australia First Pty Ltd · Phase 1 active Small molecule

At a glance

Generic name	CT-996
Also known as	RO7795081, RG6652
Sponsor	Carmot Australia First Pty Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CT-996 CI brief — competitive landscape report
CT-996 updates RSS · CI watch RSS
Carmot Australia First Pty Ltd portfolio CI